The Hydration Pharmaceuticals Co (ASX:HPC) EBIT per Share: A$-0.01 (TTM As of Dec. 2025)
What is The Hydration Pharmaceuticals Co EBIT per Share?
The Hydration Pharmaceuticals CoASX:HPC EBIT per Share is A$-0.01 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 260 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 91.15% on this metric.
The Hydration Pharmaceuticals Co's EBIT per Share for the
six
months ended in Dec. 2025 was A$-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 49.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's EBIT per Share or its related term are showing as below:
ASX:HPC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 33.2 Med: 41.5 Max: 49.8
Current: 49.8
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of The Hydration Pharmaceuticals Co was 49.80% per year. The lowest was 33.20% per year. And the median was 41.50% per year.
ASX:HPC's 3-Year EBIT Growth Rate is ranked better than 91.15% of 260
companies
in the Retail - Defensive industry
Industry Median: 11.45
vs ASX:HPC: 49.80
The Hydration Pharmaceuticals Co (ASX:HPC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
The Hydration Pharmaceuticals Co EBIT per Share Related Terms
The Hydration Pharmaceuticals Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a EBIT per Share of A$-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #23 out of 260 companies in the Retail - Defensive industry, placing it in the top 8.8%.
Is The Hydration Pharmaceuticals Co's EBIT per Share too high?
The Hydration Pharmaceuticals Co's current EBIT per Share is A$-0.01. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #23 out of 260 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's EBIT per Share compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #23 out of 260 companies for EBIT per Share. This places The Hydration Pharmaceuticals Co in the top 9% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Retail - Defensive company?
The median EBIT per Share among Retail - Defensive companies is 11.45, based on 260 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median EBIT per Share is 11.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current EBIT per Share is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current EBIT per Share of A$-0.01. The current EBIT per Share is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current EBIT per Share is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 